ClinicalTrials.Veeva

Menu

Cohort of STEMI Patients 2 (HIBISCUS STEMI)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Enrolling

Conditions

Myocardial Infarction

Treatments

Behavioral: Quality of life questionaries
Other: MRI
Biological: Biocollection

Study type

Interventional

Funder types

Other

Identifiers

NCT05794022
69HCL22_0991

Details and patient eligibility

About

ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort).

The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Diagnosis of STEMI defined by ST segment elevation ≥ 0.2 mV in 2 contiguous leads on a 12-lead ECG.
  • Management in primary ACT
  • Prior oral informed consent followed by signed informed consent as soon as possible.

Exclusion criteria

  • Diagnosis of STEMI not confirmed on angiography
  • Inability to give the subject informed information
  • Lack of coverage by a social security scheme
  • Obvious contraindication to injected magnetic resonance imaging (claustrophobia, pacemaker, defibrillator, or a metallic body (ferromagnetic), severe renal insufficiency (GFR<30 ml/min), known allergy to the contrast medium ....)
  • Pregnant woman or woman of childbearing age without effective contraception, breastfeeding woman.
  • Deprivation of civil rights (curators, guardianship, safeguard of justice)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

300 participants in 1 patient group

Cohort group
Other group
Description:
patient with ST-segment elevation myocardial infarction.
Treatment:
Biological: Biocollection
Other: MRI
Behavioral: Quality of life questionaries

Trial contacts and locations

2

Loading...

Central trial contact

Thomas BOCHATON, Dr; Yvonne VARILLON

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems